K. Lorber

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.

A. Kliger, A. Friedman, G. Basadonna, 1997, Transplantation.

The evolving role of tor inhibitors for individualizing posttransplant immunosuppression.

A. Friedman, R. Formica, G. Basadonna, 2001, Transplantation proceedings.

The evolving experience using everolimus in clinical transplantation.

A. Friedman, R. Formica, J. D. Smith, 2004, Transplantation proceedings.

Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.

A. Kliger, M. Lorber, M. Bia, 1995, Transplantation.